Innovent Biologics (HK:1801) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Innovent Biologics has decided to terminate its proposed subscription agreement with Fortvita and Lostrancos after receiving feedback from shareholders. The company remains committed to its strategic objectives and aims to focus on long-term international growth, believing that the termination is in the best interest of shareholders.
For further insights into HK:1801 stock, check out TipRanks’ Stock Analysis page.